AKUMS DRUGS & PHARMACEUTICALS
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹30 Cr | ₹15 Cr | ₹1.50 Cr |
Equity - Issued | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr |
Equity Paid Up | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹3,016 Cr | ₹681 Cr | ₹689 Cr | ₹608 Cr | ₹884 Cr |
Securities Premium | ₹1,084 Cr | ₹127 Cr | ₹127 Cr | ₹127 Cr | ₹128 Cr |
Capital Reserves | ₹103 Cr | ₹103 Cr | ₹103 Cr | ₹103 Cr | ₹103 Cr |
Profit & Loss Account Balance | ₹1,829 Cr | ₹631 Cr | ₹639 Cr | ₹558 Cr | ₹832 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | - | ₹-180 Cr | ₹-180 Cr | ₹-180 Cr | ₹-180 Cr |
Reserve excluding Revaluation Reserve | ₹3,016 Cr | ₹681 Cr | ₹689 Cr | ₹608 Cr | ₹884 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹3,047 Cr | ₹709 Cr | ₹717 Cr | ₹622 Cr | ₹885 Cr |
Minority Interest | ₹17 Cr | ₹11 Cr | ₹6.19 Cr | ₹3.20 Cr | ₹2.29 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | ₹78 Cr | ₹115 Cr | ₹13 Cr | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | ₹124 Cr | ₹149 Cr | ₹20 Cr | ₹9.85 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | ₹-46 Cr | ₹-34 Cr | ₹-6.69 Cr | ₹-9.85 Cr |
Unsecured Loans | - | - | - | - | ₹1.16 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | ₹1.16 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-189 Cr | ₹-111 Cr | ₹-6.22 Cr | ₹20 Cr | ₹27 Cr |
Deferred Tax Assets | ₹270 Cr | ₹194 Cr | ₹82 Cr | ₹43 Cr | ₹40 Cr |
Deferred Tax Liability | ₹81 Cr | ₹83 Cr | ₹76 Cr | ₹64 Cr | ₹66 Cr |
Other Long Term Liabilities | ₹102 Cr | ₹1,464 Cr | ₹1,111 Cr | ₹1,095 Cr | ₹637 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹36 Cr | ₹31 Cr | ₹26 Cr | ₹24 Cr | ₹20 Cr |
Total Non-Current Liabilities | ₹-52 Cr | ₹1,462 Cr | ₹1,246 Cr | ₹1,153 Cr | ₹685 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹643 Cr | ₹532 Cr | ₹567 Cr | ₹590 Cr | ₹341 Cr |
Sundry Creditors | ₹643 Cr | ₹532 Cr | ₹567 Cr | ₹590 Cr | ₹341 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹180 Cr | ₹253 Cr | ₹246 Cr | ₹238 Cr | ₹84 Cr |
Bank Overdraft / Short term credit | - | - | ₹3.77 Cr | ₹4.81 Cr | ₹1.66 Cr |
Advances received from customers | ₹23 Cr | ₹112 Cr | ₹108 Cr | ₹145 Cr | ₹17 Cr |
Interest Accrued But Not Due | - | - | - | - | ₹0.42 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹157 Cr | ₹141 Cr | ₹134 Cr | ₹88 Cr | ₹65 Cr |
Short Term Borrowings | ₹14 Cr | ₹368 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr |
Secured ST Loans repayable on Demands | ₹14 Cr | ₹267 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr |
Working Capital Loans- Sec | ₹14 Cr | ₹267 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-14 Cr | ₹-167 Cr | ₹-388 Cr | ₹-338 Cr | ₹-86 Cr |
Short Term Provisions | ₹58 Cr | ₹58 Cr | ₹65 Cr | ₹107 Cr | ₹68 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.40 Cr | ₹1.44 Cr | ₹19 Cr | ₹48 Cr | ₹29 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹57 Cr | ₹57 Cr | ₹46 Cr | ₹59 Cr | ₹39 Cr |
Total Current Liabilities | ₹894 Cr | ₹1,211 Cr | ₹1,266 Cr | ₹1,272 Cr | ₹580 Cr |
Total Liabilities | ₹3,905 Cr | ₹3,393 Cr | ₹3,235 Cr | ₹3,050 Cr | ₹2,152 Cr |
ASSETS | |||||
Gross Block | ₹2,252 Cr | ₹1,893 Cr | ₹1,715 Cr | ₹1,542 Cr | ₹1,325 Cr |
Less: Accumulated Depreciation | ₹854 Cr | ₹702 Cr | ₹617 Cr | ₹521 Cr | ₹421 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1,397 Cr | ₹1,191 Cr | ₹1,097 Cr | ₹1,021 Cr | ₹904 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹160 Cr | ₹195 Cr | ₹103 Cr | ₹31 Cr | ₹17 Cr |
Non Current Investments | ₹0.14 Cr | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr |
Long Term Investment | ₹0.14 Cr | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.14 Cr | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr |
Long Term Loans & Advances | ₹61 Cr | ₹56 Cr | ₹96 Cr | ₹86 Cr | ₹44 Cr |
Other Non Current Assets | ₹9.06 Cr | ₹9.74 Cr | ₹14 Cr | ₹20 Cr | ₹29 Cr |
Total Non-Current Assets | ₹1,631 Cr | ₹1,452 Cr | ₹1,311 Cr | ₹1,159 Cr | ₹995 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | ₹19 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | ₹19 Cr |
Inventories | ₹681 Cr | ₹630 Cr | ₹730 Cr | ₹722 Cr | ₹430 Cr |
Raw Materials | ₹338 Cr | ₹304 Cr | ₹362 Cr | ₹335 Cr | ₹177 Cr |
Work-in Progress | ₹75 Cr | ₹71 Cr | ₹77 Cr | ₹67 Cr | ₹34 Cr |
Finished Goods | ₹127 Cr | ₹109 Cr | ₹130 Cr | ₹160 Cr | ₹97 Cr |
Packing Materials | ₹84 Cr | ₹65 Cr | ₹82 Cr | ₹81 Cr | ₹50 Cr |
Stores  and Spare | ₹15 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹6.56 Cr |
Other Inventory | ₹41 Cr | ₹68 Cr | ₹67 Cr | ₹67 Cr | ₹65 Cr |
Sundry Debtors | ₹770 Cr | ₹834 Cr | ₹845 Cr | ₹884 Cr | ₹531 Cr |
Debtors more than Six months | ₹106 Cr | ₹107 Cr | ₹151 Cr | ₹83 Cr | ₹545 Cr |
Debtors Others | ₹714 Cr | ₹750 Cr | ₹709 Cr | ₹819 Cr | - |
Cash and Bank | ₹576 Cr | ₹277 Cr | ₹150 Cr | ₹103 Cr | ₹68 Cr |
Cash in hand | ₹0.50 Cr | ₹0.33 Cr | ₹0.25 Cr | ₹0.41 Cr | ₹0.53 Cr |
Balances at Bank | ₹576 Cr | ₹277 Cr | ₹150 Cr | ₹102 Cr | ₹67 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹32 Cr | ₹30 Cr | ₹15 Cr | ₹9.49 Cr | ₹10 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹16 Cr | ₹13 Cr | ₹9.10 Cr | ₹7.94 Cr | ₹6.47 Cr |
Other current_assets | ₹15 Cr | ₹17 Cr | ₹5.61 Cr | ₹1.55 Cr | ₹3.82 Cr |
Short Term Loans and Advances | ₹215 Cr | ₹169 Cr | ₹139 Cr | ₹145 Cr | ₹99 Cr |
Advances recoverable in cash or in kind | ₹31 Cr | ₹20 Cr | ₹25 Cr | ₹20 Cr | ₹17 Cr |
Advance income tax and TDS | - | - | ₹11 Cr | - | ₹0.16 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹184 Cr | ₹149 Cr | ₹103 Cr | ₹125 Cr | ₹82 Cr |
Total Current Assets | ₹2,275 Cr | ₹1,941 Cr | ₹1,879 Cr | ₹1,864 Cr | ₹1,157 Cr |
Net Current Assets (Including Current Investments) | ₹1,381 Cr | ₹730 Cr | ₹613 Cr | ₹592 Cr | ₹577 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹3,905 Cr | ₹3,393 Cr | ₹3,235 Cr | ₹3,050 Cr | ₹2,152 Cr |
Contingent Liabilities | ₹92 Cr | ₹89 Cr | ₹82 Cr | ₹98 Cr | ₹22 Cr |
Total Debt | ₹14 Cr | ₹492 Cr | ₹537 Cr | ₹358 Cr | ₹97 Cr |
Book Value | 199.01 | 49.59 | 50.13 | 86.95 | 6,801.28 |
Adjusted Book Value | 199.01 | 49.59 | 50.13 | 43.47 | 61.83 |
Compare Balance Sheet of peers of AKUMS DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AKUMS DRUGS & PHARMACEUTICALS | ₹9,094.6 Cr | -1.2% | 3.1% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AKUMS DRUGS & PHARMACEUTICALS | -1.2% |
3.1% |
|
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses